COPD
Conditions
Interventions
The patients continue their usual care (e.g., scheduled visits to their
pulmonologists) during the study. They receive feedback on their inhalation
errors and therapy adherence.
Sponsors
Medisch Spectrum Twente
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: Patients: - A clinical diagnosis of COPD - >= 40 years of age - Using the RS01/Breezhaler - Able to understand and read the Dutch language - In possession of a smart mobile device and WiFi at home Health care providers: Pulmonary physician or Pulmonary nurse
Exclusion criteria
Exclusion criteria: Patients: - Participation in another clinical trial involving eHealth - Presence of disease, impairing use of an inhaler (e.g., Parkinson*s disease, rheumatism)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The main study endpoints are: 1) the weekly therapy adherence to the medication taken once daily with the RS01X*, 2) the type and 3) number of errors in inhalation technique during the four weeks patients will use the RS01X* at home, and 4) the type and 5) number of errors made at the start and the end of the study during the observation of the inhalation technique. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary endpoints are: 1) the usability of the application for patients, 2) the ease of linking the RS01X* with the application and 3) the usability of the HCP portal. | — |
Countries
Netherlands
Outcome results
None listed